Back to search
FDAFDA · Food and drugs·Recall number F-2399-2014

PHENTALENE (TM), PHARMACEUTICAL GRADE, With 50 mg of Ephedra Extract, 90 CAPSULES, Distributed by Beta Labs, LTD, Newark, DE 19711, UPC 670541599822

Published September 3, 2014 · Recall initiated: June 20, 2013

Summary

FDA records food Class I recall F-2399-2014, published September 3, 2014 and initiated June 20, 2013. Recalling firm: Beta Labs; Status: Terminated; Reported quantity: 2154 units; Lot: Lot # 58800512, Exp 05/16. Class I means a reasonable probability of serious adverse health consequences or death.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

The products contain DMAA, also known as 1,3-dimethylamylamine, methylhexamine or geranium extract, which is not permitted in dietary supplements.

What to do

Voluntary: Firm initiated · Press Release

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Beta Labs
Distributor
nationwide and UK
UPC
670541599822
Lot
Lot # 58800512, Exp 05/16
Risk classification
Class I
Area (FDA)
food
Country
United States

Related recalls

Questions about this recall

Was PHENTALENE (TM), PHARMACEUTICAL GRADE, With 50 mg of Ephedra Extract, 90 CAPSULES, Distributed by Beta Labs, LTD, Newark, DE 19711, UPC 670541599822 recalled?

Yes. FDA published recall F-2399-2014 on September 3, 2014. Reported hazard: The products contain DMAA, also known as 1,3-dimethylamylamine, methylhexamine or geranium extract, which is not permitted in dietary supplements.

What should I do if I have this product?

Voluntary: Firm initiated · Press Release

How do I know if my unit is part of the recall?

Compare your product details with the notice. UPC: 670541599822.